Acceleron Pharma Inc

Ownership Transactions Reported by 13 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
128 Sidney Street, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 12/31/2023

Acceleron Pharma Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sujay Kango EVP, Chief Commercial Officer Nov 19, 2021
Joseph S. Zakrzewski Director Nov 19, 2021
M. Veness SVP, General Counsel and Sec. Nov 19, 2021
Thomas A. MCCOURT Director Nov 19, 2021
Kemal Malik Director Nov 19, 2021
Jay T. Backstrom EVP, Research and Development Nov 19, 2021
Kevin Mclaughlin SVP, CFO and Treasurer Nov 19, 2021
Karen L. Smith Director Nov 19, 2021
Francois Nader Director Nov 19, 2021
Laura Hamill Director Nov 19, 2021
Terrence C. Kearney Director Nov 19, 2021
Christopher Hite Director Nov 19, 2021
Habib J. Dable CEO and President, Director Nov 19, 2021

Recent Insider Transactions by Companies or Individuals for Acceleron Pharma Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.